Takeda Pharmaceutical Co Ltd
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1395064. Latest Form 4 filed May 5, 2021.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc.PHAT | 10% owner | 55 | 2021-05-03 | 2024-01-24 |
Transactions: 55
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2021-05-04 | Phathom Pharmaceuticals, Inc.10% owner | Sale | 4,690 | $36.21 | $169.8k | Form 4 |
| 2021-05-04 | Phathom Pharmaceuticals, Inc.10% owner | Sale | 11,070 | $35.50 | $393.0k | Form 4 |
| 2021-05-03 | Phathom Pharmaceuticals, Inc.10% owner | Sale | 203 | $39.06 | $7.9k | Form 4 |
| 2021-05-03 | Phathom Pharmaceuticals, Inc.10% owner | Sale | 11,272 | $38.45 | $433.4k | Form 4 |
| 2021-05-03 | Phathom Pharmaceuticals, Inc.10% owner | Sale | 3,157 | $37.60 | $118.7k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 03:55 ET. Listed shows no prices and gives no investment advice.